報價延遲最少15分鐘:2024/12/23 22:16 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.65 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.34/-0.77
|
|
企業價值
613.31M
|
| 資產負債 |
|
每股賬面淨值
-0.50
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2024/12/23 22:16 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. |